Literature DB >> 10091826

Assessment of regional and global left ventricular function by reinjection T1-201 and rest Tc-99m sestamibi ECG-gated SPECT: comparison with three-dimensional magnetic resonance imaging.

E Tadamura1, T Kudoh, M Motooka, M Inubushi, S Shirakawa, N Hattori, T Okada, T Matsuda, T Koshiji, K Nishimura, K Matsuda, J Konishi.   

Abstract

OBJECTIVES: The purpose of this study was to test the ability of reinjection thallium-201 and rest technetium-99m sestamibi ECG (electrocardiographic)-gated SPECT (i.e., reinjection-g-SPECT [single-photon emission computed tomography] and MIBI-g-SPECT) to determine regional and global functional parameters.
BACKGROUND: The ECG-gated perfusion SPECT was reported to provide accurate left ventricular ejection fraction (LVEF) using an automated algorithm. We hypothesized that other various functional data may be obtained using reinjection-g-SPECT and MIBI-g-SPECT.
METHODS: Reinjection-g-SPECT, MIBI-g-SPECT, and three-dimensional magnetic resonance imaging (3DMRI) were conducted in 20 patients with coronary artery disease. Regional wall motion (RWM) and wall thickening (RWT) were analyzed using semiquantitative visual scoring by each g-SPECT and 3DMRI. The left ventricular end-systolic and end-diastolic volumes (EDV, ESV) and LVEF estimated by reinjection- and MIBI-g-SPECT were compared with the results of 3DMRI.
RESULTS: A high degree of agreement in RWM and RWT assessment was observed between each g-SPECT and 3DMRI (kappa >.70, p < .001). The LVEF values by reinjection- and MIBI-g-SPECT correlated and agreed well with those by 3DMRI (reinjection: r = .92, SEE = 5.9%, SD of differences = 5.7%; sestamibi: r = .94, SEE = 4.4%, SD of differences = 5.1%). The same also pertained to EDV (reinjection: r = .85, SEE = 18.7 ml, SD of differences = 18.4 ml; sestamibi: r = .92, SEE = 13.1 ml, SD of differences = 13.0 ml) and ESV (reinjection: r = .94, SEE = 10.3 ml, SD of differences = 10.3 ml; sestamibi: r = .97, SEE = 6.7 ml [p < .05 vs. reinjection by F test], SD of differences = 6.6 ml [p < .05 vs. reinjection by F test]).
CONCLUSIONS: Reinjection- and MIBI-g-SPECT provide clinically satisfactory various functional data. These functional data in combination with the perfusion information will improve diagnostic and prognostic accuracy without an increase in cost or the radiation dose to the patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10091826     DOI: 10.1016/s0735-1097(98)00661-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  32 in total

1.  Evaluation of left ventricular endocardial volumes and ejection fractions computed from gated perfusion SPECT with magnetic resonance imaging: comparison of two methods.

Authors:  T L Faber; J P Vansant; R I Pettigrew; J R Galt; M Blais; G Chatzimavroudis; C D Cooke; R D Folks; S M Waldrop; E Gurtler-Krawczynska; M D Wittry; E V Garcia
Journal:  J Nucl Cardiol       Date:  2001 Nov-Dec       Impact factor: 5.952

2.  Comparative value of ECG-gated blood pool SPET and ECG-gated myocardial perfusion SPET in the assessment of global systolic left ventricular function.

Authors:  Doumit Daou; Didier Vilain; Patrice Colin; Rachida Lebtahi; Thierry Fourme; Carlos Coaguila; Abdel Benada; Ilana Idy-Peretti; Michel Slama; Dominique Le Guludec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-04       Impact factor: 9.236

3.  Validation of 4D-MSPECT and QGS for quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPET: comparison with cardiac magnetic resonance imaging.

Authors:  Claudia S A Lipke; Harald P Kühl; Bernd Nowak; Hans-Juergen Kaiser; Patrick Reinartz; Karl-Christian Koch; Udalrich Buell; Wolfgang M Schaefer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

4.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

Review 5.  Gated SPECT in assessment of regional and global left ventricular function: major tool of modern nuclear imaging.

Authors:  Aiden Abidov; Guido Germano; Rory Hachamovitch; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

6.  Noninvasive modalities for the assessment of left ventricular function: all are equal but some are more equal than others.

Authors:  Tiong Keng Lim; Roxy Senior
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

7.  Quantitation in gated perfusion SPECT imaging: the Cedars-Sinai approach.

Authors:  Guido Germano; Paul B Kavanagh; Piotr J Slomka; Serge D Van Kriekinge; Geoff Pollard; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 8.  Gated SPECT in assessment of regional and global left ventricular function: an update.

Authors:  Aiden Abidov; Guido Germano; Rory Hachamovitch; Piotr Slomka; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

Review 9.  SPECT and PET in ischemic heart failure.

Authors:  George Angelidis; Gregory Giamouzis; Georgios Karagiannis; Javed Butler; Ioannis Tsougos; Varvara Valotassiou; George Giannakoulas; Nikolaos Dimakopoulos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis; Panagiotis Georgoulias
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

10.  Comparison of contrast enhanced three dimensional echocardiography with MIBI gated SPECT for the evaluation of left ventricular function.

Authors:  Bernard Cosyns; David Haberman; Steven Droogmans; Sandrine Warzée; Philippe Mahieu; Eric Laurent; Marie Moonen; Sophie Hernot; Patrizio Lancellotti
Journal:  Cardiovasc Ultrasound       Date:  2009-06-16       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.